Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | RECQL | P46063 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.35 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.35 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
| ▸ | BCL2 | P10415 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GNG2 | P59768 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658588 | 1.00 | KDM4E (0.35) | KDM4EMAPTRECQLMEN1ALDH1A1 | |
| SCHEMBL27441448 | 0.84 | PLK1 (0.40) | KDM4EMAPTRECQLMEN1ALDH1A1 | |
| SCHEMBL30689853 | 0.84 | CA1 (0.39) | KDM4EMAPTRECQLMEN1ALDH1A1 | |
| SCHEMBL3698500 | 0.84 | CA1 (0.39) | KDM4EMAPTRECQLMEN1ALDH1A1 | |
| SCHEMBL28686647 | 0.82 | RIPK1 (0.33) | KDM4EMAPTRECQLMEN1ALDH1A1 | |
| Flavanone SCHEMBL3438656 | 0.82 | MAOB (0.53) | KDM4EMAPTMEN1CYP3A4MAOA | |
| SCHEMBL725961 | 0.80 | MEN1 (0.31) | KDM4EMAPTRECQLMEN1ALDH1A1 | |
| SCHEMBL29740777 | 0.76 | HSP90AA1 (0.34) | MAPTRECQLMEN1ALDH1A1CYP3A4 | |
| SCHEMBL727643 | 0.73 | MAPT (0.40) | MAPTRECQLALDH1A1CYP3A4HPGD | |
| SCHEMBL28515636 | 0.73 | ADAMTS4 (0.33) | RECQLALDH1A1HPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109172640-A | Application of the flavones ingredient in the drug for preparing anti-oral cavity bacterial diseases in paper mulberry | 中国科学院昆明植物研究所 | 2019-01-11 | — | — | CN | claimed |
| EP-2875359-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS | Charles R Drew University of Medicine and Science (US) | 2015-05-27 | — | — | EP | claimed |
| WO-2013149258-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS | Charles Drew University of Medicine and Science (US) | 2013-10-03 | — | — | WO | claimed |
| US-7338791-B2 | Introducing the set of genes into a heterologous host cell, allowing growth of the cells in a suitable medium such that the expression of the genes results in production of enzymes; culturing the cell under conditions permitting the synthesis of the flavonoid by the cells; isolating s flavonoids | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2008-03-04 | — | — | US | claimed |
| WO-2006024545-A1 | FUSED BICYCLIC NATURAL COMPOUNDS AND THEIR USE AS INHIBITORS OF PARP AND PARP-MEDIATED INFLAMMATORY PROCESSES | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2006-03-09 | — | — | WO | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| US-20240263203-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF TETRAKETIDE DERIVATIVES | IPTECTOR ASSETS APS (DK) | 2024-08-08 | — | — | US | disclosed |
| WO-2023230574-A1 | ENGINEERED PHENYLALANINE AMMONIA LYASE AND TYROSINE AMMONIA LYASE ENZYMES FOR PRODUCING AROMATIC COMPOUNDS | GINKGO BIOWORKS, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20220228190-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-07-21 | — | — | US | disclosed |
| EP-3906301-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF TETRAKETIDE DERIVATIVES | Barrit Sarl (FR) | 2021-11-10 | — | — | EP | disclosed |
| CN-113384622-A | Application of semen plantaginis extract in preparing medicine for treating myocardial hypertrophy | 上海中医药大学 | 2021-09-14 | — | — | CN | disclosed |
| US-5569832-A | DIHYDROKAEMFEROL (DHK) HYDROXYLATING ENZYME, FLOWER COLOR | INTERNATIONAL FLOWER DEVELOPMENTS PTY. LTD. (AU) | 1996-10-29 | — | — | US | disclosed |
| EP-0703982-A4 | — | — | 1996-04-17 | — | — | EP | disclosed |
| EP-0703982-A1 | TRANSGENIC FLOWERING PLANTS | INTERNATIONAL FLOWER DEVELOPMENTS Pty. Ltd. (AU) | 1996-04-03 | — | — | EP | disclosed |
| WO-1994028140-A1 | TRANSGENIC FLOWERING PLANTS | INTERNATIONAL FLOWER DEVELOPMENTS PTY. LTD. (AU) | 1994-12-08 | — | — | WO | disclosed |
| US-5349125-A | Flower pigmentation | INTERNATIONAL FLOWER DEVELOPMENTS PTY. LTD. (AU) | 1994-09-20 | — | — | US | disclosed |
| CN-1071456-A | Genetic sequences encoding flavonoid pathway enzymes and uses thereof | INT FLOWER DEV PTY LTD (AU) | 1993-04-28 | — | — | CN | disclosed |
| WO-1993001290-A1 | GENETIC SEQUENCES ENCODING FLAVONOID PATHWAY ENZYMES AND USES THEREFOR | INTERNATIONAL FLOWER DEVELOPMENTS PTY. LTD. (AU) | 1993-01-21 | — | — | WO | disclosed |
| EP-0522880-A2 | Genetic sequences encoding flavonoid pathway enzymes and uses therefor | INTERNATIONAL FLOWER DEVELOPMENTS Pty. Ltd. (AU) | 1993-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | KDM4E 2737/4885MAPT 1771/4885RECQL 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.